As of January 2025 ImmunoPrecise Antibodies has a market cap of A$22.48 Million. This makes ImmunoPrecise Antibodies the world's 10014th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 2nd, 2025 the market cap of ImmunoPrecise Antibodies was reported to be: